579
Participants
Start Date
November 3, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Burjeel Medical City /ID# 259407, Abu Dhabi
National Taiwan University Hospital /ID# 261542, Taipei City
Hospital Italiano de Buenos Aires /ID# 256999, Ciudad Autonoma Buenos Aires
Instituto Alexander Fleming /ID# 256295, Ciudad Autonoma de Buenos Aire
Universitätsspital Basel /ID# 256677, Basel Town
University Hospital Zurich /ID# 256678, Zurich
West China Hospital, Sichuan University /ID# 256906, Chengdu
Rambam Health Care Campus /ID# 256546, Haifa
Irmandade da Santa Casa de Misericordia de Porto Alegre /ID# 256487, Porto Alegre
Hospital Alemao Oswaldo Cruz /ID# 256486, São Paulo
Nova Scotia Health Authority /ID# 256950, Halifax
Institut universitaire de cardiologie et de pneumologie de Québec - Université L /ID# 257872, Québec
Royal University Hospital /ID# 261272, Saskatoon
Kindai University Hospital /ID# 257890, Osakasayama-shi
National Cancer Center Hospital /ID# 257889, Chuo-ku
The Catholic University of Korea, Yeouido ST. Mary's Hospital /ID# 261511, Seoul
UOMi Cancer Center - Clinica Tres Torres /ID# 261212, Barcelona
Queen's University Belfast /ID# 258458, Belfast
University Hospitals Birmingham NHS Foundation Trust /ID# 260991, Birmingham
Lead Sponsor
AbbVie
INDUSTRY